ITI Scotland| ITI Energy| ITI Techmedia
Latest Headlines
Past Press Releases
E-Newsletter
Public Documents
home  » news » latest headlines » past press releases

Past Press Releases

As well as the news releases, we also publish factsheets on each of our commissioned programmes.


Interim CEO announced
31 October 2005
Dr Eleanor Mitchell, currently Director of Programmes at ITI Life Sciences, has been appointed interim CEO
News Article
more details »

ITI Life Sciences Appoints John Henderson and Giovanni Ferrara to its Advisory Board
20 October 2005
ITI Life Sciences, the Scotland-based innovation fund, today announces the appointments of two new members to its Advisory Board: John Henderson, President of FuturePharm LLC; and Giovanni A. Ferrara, a Managing Director of US life sciences merchant bank Burrill & Company.
Press Release
more details »

ITI Life Sciences CEO, John Chiplin, Resigns
4 October 2005
The Board of ITI Scotland Limited today announced that John Chiplin has resigned as Chief Executive Officer of ITI Life Sciences, based in Dundee, to take up a new appointment as Chief Executive Officer of Australian biotechnology company Peptech Limited (ASX: PTD)
Press Release
more details »

ITI Life Sciences Launches £5.3 Million Text Mining R&D Programme
15 March 2005
University of Edinburgh and Cognia to develop powerful new tools to extract key information from the growing mountain of life sciences data
Press Release
more details »

ITI Life Sciences commits £30 million to new R&D programme
28 February 2005
New company – Stirling Medical Innovations – established to develop near-patient and home use diagnostic tests based on novel biomarker technologies
Press Release
more details »

ITI Life Sciences Launches New R&D Programme
24 February 2005
£5.5 million to develop new predictive safety models for early drug development
Press Release
more details »

ITI Life Sciences Launches First R&D Programme in Scotland
8 February 2005
£3.7 million to develop 3-dimensional cell-based assays with fluorescence lifetime detection technology
Press Release
more details »

ITI Life Sciences CEO John Chiplin to present at BioJapan 2004
30 September 2004
ITI Life Sciences CEO John Chiplin presents at BioJapan 2004 and welcomes its first Japanese Members
Press Release
more details »

World class figures from business and academia join ITI Life Sciences Advisory Board
12 May 2004
ITI Life Sciences, the centre for identifying technologies for future emerging markets in a range of sectors; including pharmaceuticals, biotechnology, medical devices and diagnostics, has made a number of distinguished international appointments to its Advisory Board.
Press Release
more details »


« Page 4 of 4
1 | 2 | 3 | 4



ITI Life Sciences invests £2.5m in R&D programme to advance efficiency of Synthetic Biology »
Genome Segment Assembly programme launches with research providers Heriot Watt University and Gingko Bioworks


New Environmental Scan looking at Immunotherapies »
Our reports gives an overview of the whole immunotherapies field focusing on market opportunities. Click the link above to download it now.


Membership is now free »
Sign up today to gain access to our back catalogue of foresighting reports